Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2914
Selected: 0
NCT IDTitle
NCT03044873Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin
NCT07679061First-Line Nivolumab Plus Ipilimumab in Unresectable Hepatocellular Carcinoma (J-PROMISE)
NCT07283705A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer
NCT00035542A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.
NCT01193361Ph IIA Study (SOC +/- NS5B)
NCT00000954A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma
NCT06715683A Study to Evaluate Comparative Bioavailability of BMS-986278 in Healthy Participants
NCT04620954Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin
NCT07011745A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
NCT00313300Safety Study of Apixaban in Recent Acute Coronary Syndrome
NCT01795911Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
NCT05409157A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants
NCT01309945Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
NCT03177239Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602)
NCT04895709A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
NCT03745807An Investigational Study of NKTR-214 Combined With Nivolumab in Japanese Participants With Advanced Solid Tumors
NCT05414175A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy
NCT07599007Repotrectinib Post-Marketing Surveillance in Korean Patients With ROS1-Positive Non-Small Cell Lung Cancer (NSCLC) or Solid Tumors Harboring a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion
NCT02581644Assessment of Effectiveness of Belatacept Patient Alert Card in Patients Following Renal Transplantation in a Sample of EU Countries
NCT00505245New Assessment System in Measuring Symptom Distress in Cancer Patients
NCT00388609Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BMS-646256 in Obese Subjects
NCT03770299An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease
NCT04448964A Study of JNJ-70033093 in Healthy Participants
NCT03071406Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
NCT01511809Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression
NCT01215487A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With Imatinib
NCT02775292Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1
NCT00279409Treatment of Children With ADHD Who do Not Fully Respond to Stimulants
NCT03168464Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)
NCT03461952Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood (NIMBLe)
NCT02754141An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab
NCT06762769Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma
NCT06452329A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction Cancer
NCT00326586A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer
NCT01835470Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan
NCT00002420The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
NCT03771859A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed
NCT00430027Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma
NCT01540461Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)
NCT04717154Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate Cancer
NCT03090737Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer
NCT04464577A Study to Evaluate the Effect of Fluconazole, Bupropion, or Itraconazole on the Drug Levels and Safety of BMS-986235
NCT05662241A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
NCT03924401Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant
NCT01995266Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual
NCT00282139Aripiprazole in the Treatment of Tourette's Syndrome
NCT00035555Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney
NCT01525810Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial
NCT00992420Genotype Information and Functional Testing Study
NCT07008820Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan